Cathepsin D expression in colorectal adenocarcinomas and adenomas

International Journal of Biological Markers

Volumn 17, Issue 3, 2002, Pages 165-168

  Kanber, Yonca ^a   Demirbag, N R ^a   Sam, A D ^a   Aydin, N ^a  

^a AD Kmaras   (Turkey)

Author keywords

Adenocarcinoma; Cathepsin D; Colon

Indexed keywords

CATHEPSIN D;

ADENOCARCINOMA; ADENOMA; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL PARAMETERS; LYMPH NODE METASTASIS; LYMPH VESSEL; MALE; PROGNOSIS; PROTEIN EXPRESSION; STAINING; STATISTICAL SIGNIFICANCE; STROMA CELL; TUMOR CELL;

EID: 0036662558     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460080201700304     Document Type: Article

References (23)

1. Rochefort H. Cathepsin D in breast cancer. Breast Cancer Res Treat 1990; 16: 3-13.
2. Caruso ML, Valentini AM. Immunohistochemical p53 overexpression correlated to c-erbB-2 and Cathepsin D proteins in colorectal cancer. Anticancer Res 1996; 16: 3813-8.
3. Ioachim EE, Goussia AC, Machera M, Tsianos EV, Kappas AM, Agnantis NJ. Immunohistochemical evaluation of Cathepsin D expression in colorectal tumours: A correlation with extracellular matrix components, p53, pRp, bcl-2, c-erbB-2, EGFR and proliferation indices. Anticancer Res 1999; 19: 2147-56.
4. Roger P, Moncourrier P, Maudelonde T, et al. Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: Correlation with cytosolic assay. Hum Pathol 1994; 25: 863-71.
5. Theodoropoulos G, Pnoussopoulos D, Lazaris A, Golematis B. Evaluation of cathepsin D immunostaining in colorectal adenocarcinoma. J Surg Oncol 1997; 65: 242-8.
6. Tetu B, Brisson J, Cote C, Brisson S, Potvin D, Roberge N. Prognostic significance of cathepsin D expression in node-positive breast carcinoma: An immunohistochemical study. Int J Cancer 1993; 55: 429-35.
7. Gonzalez-Vela M, Garijo MF, Fernandez F, Buelta L, Val-Bernal JF. Cathepsin D in host stromal cells is associated with more highly vascular and aggressive invasive breast carcinoma. Histopathology 1999; 34: 35-42.
8. Fusek M, Vetvika V. Mitogenic function of procathepsin D: the role of the propeptide. Biochem J 1991; 303: 775-80.
9. Tuminello FM, Gebbia N, Pizzolanti C, Russo A, Bazan V, Leto G. Cathepsin D content in colorectal cancer. Oncology 1995; 52: 237-42.
10. Vignon F, Capony F, Chambon M, Freiss G, Garcia M, Rochefort H. Autocrine growth stimulation of the MCF7 breast cancer cells by the estrogen-regulated 52 K protein. Endocrinology 1986; 118: 1537-45.
11. Vetvicka V, Vetvickova J, Fusek M. Effect of human Cathepsin D on proliferation of human cell lines. Cancer Lett 1994; 79: 131-5.
12. Takahashi H, Mitomi H, Igarashi M, Katsumata T, Okayasu I. Markedly elevated cell turnover is characteristic of small, deeply invasive carcinomas of the colorectum. Cancer 1999; 85: 796-802.
13. Nadji M, Fresno M, Nassari M, Conner G, Herrero A, Morales AR. Cathepsin D in host stromal cells, but not in tumor cells is associated with aggressive behavior in node negative breast cancer. Hum Pathol 1996; 27: 890-5.
14. Isola J, Weitz S, Visakorpi T, et al. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary-node negative breast cancer. J Clin Oncol 1993; 11:36-43.
15. Thorpe S, Rochefort H, Garcia M, et al. Association between high concentrations of Mr 52,000 Cathepsin D and poor prognosis in primary human breast cancer. Cancer Res 1989; 49: 6008-14.
16. Ravdin P, Tandon A, Allred C, et al. Cathepsin D by Western blotting and immunohistochemistry: Failure to confirm correlations with prognosis in node-negative breast cancer. J Clin Oncol 1994; 12: 467-74.
17. Saku T, Sakai H, Tsuda N, Okabe H, Kato Y, Yamamoto K. Cathepsins D and E in normal, metaplastic, dysplastic, and carcinomatous gastric tissue: an immunohistochemical study. Gut 1990; 31: 1250-5.
18. Garcia I, Vizoro F, Suarez C, et al. Relationship of tumoral hyaluronic acid and cathepsin D contents with histologic type of gastric carcinoma. Int J Biol Markers 2000; 15: 215-8.
19. Villar C, Rodriguez JC, Raigoso PF, Garcia-Muniz JL, Martinez E, Vizoso V, Cathepsin D cytosol content in colorectal cancer. Int J Biol Markers 1999; 14: 192-4.
20. Ikegushi M, Fukuda K, Oka S-I, et al. Clinicopathological significance of Cathepsin D expression in gastric adenocarcinoma. Oncology 2001; 61: 71-8.
21. Valentini AM, Pirrelli M, Armentano R, Caruso ML. The immunohistochemical expression of Cathepsin D in colorectal cancer. Anticancer Res 1996; 16: 77-80.
22. Arao J, Fukui H, Ono Y, Ueda Y, Chiba T, Fujimori T. Immunohistochemical localization of Cathepsin D in colorectal tumors. Dis Colon Rectum 2000; 43: 396-401.
23. Mayer A, Fritz E, Fortelny R, Kofler K, Ludwig H. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer. Cancer Invest 1997; 15: 106-10.